Last updated on November 2019

GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Brief description of study

The purpose of this study is to assess the impact and safety of itacitinib in combination with calcineurin inhibitor (CNI)-based interventions for the prophylaxis of graft-versus-host-disease (GVHD).

Clinical Study Identifier: NCT03320642

Find a site near you

Start Over

University of Maryland Medical Center

Baltimore, MD United States
  Connect »